This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ventas, Inc. is a healthcare real estate investment trust (REIT) that is primarily engaged in acquisition and ownership of senior housing, R&I and healthcare properties, and leasing them to unaffiliated tenants or operating them through independent third-party managers. Ventas offers MOB management, leasing, marketing, facility development and advisory services to well-rated hospitals and health systems throughout the United States through its ownership interest in PMB Real Estate Services LLC and the company’s subsidiary, Lillibridge Healthcare Services, Inc. It also makes secured and non-mortgage loans and other investments relating to senior housing and healthcare properties or operators.
SBAC Stock Has Risen 10.4% Year to Date: Will the Trend Continue?
by Zacks Equity Research
SBAC is set for healthy growth with extensive infrastructure assets amid rising consumer demand and adoption of data-driven mobile devices and applications.
Key Reasons to Add Ventas Stock to Your Portfolio Right Now
by Zacks Equity Research
VTR is set to gain from rising healthcare spending amid an aging population. Accretive investments in the research portfolio and solid balance sheet bode well.
Key Reasons to Add SL Green to Your Portfolio Right Now
by Zacks Equity Research
SLG is set to gain from high demand for top-quality office properties, a diverse tenant base and its focus on opportunistic investments.
4 Reasons to Add Welltower Stock to Your Portfolio Right Now
by Zacks Equity Research
A rise in the senior citizen population and healthcare expenses, capital-recycling efforts and a healthy balance sheet are likely to support WELL stock.
Ventas Stock Gains 14.1% in Three Months: Will the Trend Last?
by Zacks Equity Research
VTR is likely to gain from an aging population, rising healthcare expenses, favorable outpatient visit trends and accretive investments in its research portfolio.
What's in the Cards for Medical Properties in Q4 Earnings?
by Zacks Equity Research
While MPW's Q4 earnings are likely to have benefited from the favorable healthcare industry trends, exposure to certain troubled operators may have hurt it.
SBA Communications Q4 AFFO & Revenues Beat Estimates, Dividend Hiked
by Zacks Equity Research
SBAC's Q4 results reflect growth in site-leasing and site-development revenues.
Gladstone Commercial Grows Industrial Property Base With Acquisition
by Zacks Equity Research
As part of its efforts to expand in strong industrial locations, GOOD acquires an industrial manufacturing facility in Houston, TX.
All You Need to Know About Ventas (VTR) Rating Upgrade to Buy
by Zacks Equity Research
Ventas (VTR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Lamar Q4 AFFO Meets Estimates, Revenues Miss, Stock Down 7.3%
by Zacks Equity Research
LAMR's Q4 results reflect growth in revenues. However, higher expenses marred the performance to some extent.
Host Hotels Q4 FFO & Revenues Top Estimates, Hotel RevPAR Rises
by Zacks Equity Research
HST's Q4 results reflect higher revenues due to better comparable hotel total RevPAR, driven by improved food and beverage revenues from the group business.
Iron Mountain Beats on Q4 FFO, Lags on Revenues, Hikes Dividend
by Zacks Equity Research
IRM's Q4 results reflect solid performance in all business segments but are marred by higher interest expenses year over year.
Ventas Q4 FFO and Revenues Top Estimates, Same-Store Cash NOI Rises
by Zacks Equity Research
VTR's Q4 results reflect higher same-store cash NOI due to SHOP same-store average occupancy growth.
Compared to Estimates, Ventas (VTR) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ventas (VTR) Tops Q4 FFO and Revenue Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of 1.25% and 2.23%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Ventas Stock This Earnings Season?
by Zacks Equity Research
While VTR's Q4 earnings are likely to have benefited from favorable SHOP operating trends and a well-diversified tenant base, high interest expenses may have hurt it.
Alexander's (ALX) Q4 FFO and Revenues Surpass Estimates
by Zacks Equity Research
Alexander's (ALX) delivered FFO and revenue surprises of 9.43% and 1.29%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Seeking Clues to Ventas (VTR) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Healthpeak's Q4 FFO Beats Estimates, Same-Store NOI Rises
by Zacks Equity Research
DOC's Q4 FFO tops estimates. Results reflect a year-over-year rise in revenues and total merger-combined same-store cash (adjusted) NOI.
What's in the Cards for Camden Property Stock This Earnings Season?
by Zacks Equity Research
CPT's Q4 results are likely to have been hurt by low rent rates amid high unit supply, affecting revenues and FFO growth.
UDR Readies to Report Q4 Earnings: What's in the Offing for the Stock?
by Zacks Equity Research
UDR's Q4 earnings are likely to have gained from portfolio diversification and technological initiatives, though high supply may have acted as a dampener.
What's in Store for Mid-America Apartment Stock in Q4 Earnings?
by Zacks Equity Research
While MAA is likely to have experienced decent demand, the rising supply of rental units and high interest expenses are concerns in Q4.
What's in Store for Essex Property This Earnings Season?
by Zacks Equity Research
Despite elevated supply, ESS' Q4 results are likely to show the benefits of a solid property base, healthy demand and technological initiatives.
What to Expect From AvalonBay Communities in Q4 Earnings?
by Zacks Equity Research
AvalonBay's Q4 results are likely to show the benefits of its diversified portfolio and technological initiatives despite elevated deliveries and high interest expenses.
Is a Beat in Store for Equity Residential Stock in Q4 Earnings?
by Zacks Equity Research
Despite high supply, EQR's Q4 results are likely to benefit from its portfolio diversification efforts and technology investments amid healthy demand.